Clinical Report |
STACEY M. LAVSA, PHARM.D., is Clinical Pharmacist, University of Pittsburgh Medical Center (UPMC), Pittsburgh, PA. TANYA J. FABIAN, PHARM.D., PH.D., BCPP, is Assistant Professor of Pharmacy and Therapeutics and Psychiatry, Schools of Pharmacy and Medicine, University of Pittsburgh (UP), Pittsburgh, and Director of Pharmacy Research and Pharmacy Services, Western Psychiatric Institute and Clinic, UPMC. MELISSA I. SAUL, M.S., is Director of Clinical Research Informatics Services, School of Medicine, UP. SHELBY L. CORMAN, PHARM.D., BCPS, is Assistant Professor of Pharmacy and Therapeutics, School of Pharmacy, UP, and Clinical Specialist, Drug Information, UPMC. KIM C. COLEY, PHARM.D., FCCP, is Professor of Pharmacy and Therapeutics, School of Pharmacy, UP
Address correspondence to Dr. Coley at the School of Pharmacy, University of Pittsburgh, 921 Salk Hall, 3501 Terrace Street, Pittsburgh, PA 15261 (coley{at}pitt.edu).
Methods. In this retrospective case–control study, psychiatric inpatients age 18 years or older with a documented fall that was reported served as study cases. These patients were matched to control patients from the same hospital (1:1) by admission year, sex, and age. Psychiatric diagnoses evaluated included major depressive disorder, schizophrenia or schizoaffective disorder, bipolar disorder, Alzheimers disease and dementia, anxiety or neurosis, delirium, personality disorder, and obsessive-compulsive disorder. Medications assessed as independent variables were conventional antipsychotics, atypical antipsychotics, selective serotonin-reuptake inhibitors, tricyclic antidepressants, atypical antidepressants, monoamine oxidase inhibitors, lithium, anticonvulsants, benzodiazepines, nonbenzodiazepine sleep aids, Alzheimers disease medications, antihistamines, antiarrhythmics, antihypertensives, benign prostatic hyperplasia medications, oral hypoglycemic agents, histamine H2-receptor blockers, laxatives and stool softeners, muscle relaxants, nonsteroidal antiinflammatory drugs, opioids, Parkinsons disease medications, and overactive bladder medications. Univariate logistic regression models were developed for each risk factor to determine its impact on fall risk.
Results. A total of 774 patient cases were matched with controls. Most falls occurred on the second day of hospitalization. Medications associated with a higher risk of falls were
Conclusion. Alpha-blockers, nonbenzodiazepine sleep aids, benzodiazepines, H2-blockers, lithium, atypical antipsychotics, atypical antidepressants, anticonvulsants and mood stabilizers, conventional anti-psychotics, laxatives and stool softeners, and dementia and Alzheimers disease were significant predictors of inpatient falls in a psychiatric population.
Index terms: Accidental falls; Alzheimer disease; Anticonvulsants; Antidepressants; Antimanic agents; Antipsychotic agents; Anxiolytics; sedatives and hypnotics; Benzodiazepines; Dementia; Gastrointestinal drugs; Laxatives and cathartics; Lithium; Mental disorders; Patients; Sympatholytic agents; Toxicity
Purpose. The influence of medications and diagnoses on fall risk in psychiatric inpatients was evaluated.
-blockers, nonbenzodiazepine sleep aids, benzodiazepines, H2-blockers, lithium, antipsychotics, atypical antidepressants, anticonvulsants, and laxatives and stool softeners. Patients with a diagnosis of dementia and Alzheimers disease also had an increased risk of falling.
![]()
CiteULike
Connotea
Del.icio.us
Digg
Facebook
Reddit
Technorati
Twitter What's this?